New vistas on cannabis use disorder

Neuropharmacology

Volumn 124, Issue , 2017, Pages 62-72

  Melis, Miriam ^a   Frau, Roberto ^a   Kalivas, Peter W ^b   Spencer, Sade ^b   Chioma, Vivian ^b   Zamberletti, Erica ^c   Rubino, Tiziana ^c   Parolaro, Daniela ^c,d  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY OF INSUBRIA   (Italy)

^d Zardi Gori Foundation   (Italy)

Author keywords

Cannabis use disorder; Glia cells; Perinatal cannabis; Reward; THC self administration

Indexed keywords

CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CYCLOOXYGENASE 2; DRONABINOL; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR;

ASTROCYTE; CANNABIS ADDICTION; CELL POPULATION; CONDITIONED PLACE PREFERENCE TEST; DOWN REGULATION; DRUG DISCRIMINATION TEST; ENZYME ACTIVATION; ENZYME INHIBITION; GLIA CELL; HUMAN; INTRACRANIAL SELF STIMULATION TEST; LONGITUDINAL STUDY; MICROGLIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SELF ADMINISTRATION TEST; SIGNAL TRANSDUCTION; ANIMAL; DISEASE MODEL; DRUG EFFECT; DRUG INDUCED MALFORMATION; GLIA; PATHOPHYSIOLOGY;

ABNORMALITIES, DRUG-INDUCED; ANIMALS; DISEASE MODELS, ANIMAL; MARIJUANA ABUSE; NEUROGLIA;

EID: 85017122524     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2017.03.033     Document Type: Review

References (144)

1. Albayram, O., Alferink, J., Pitsch, J., Piyanova, A., Neitzert, K., Poppensieker, K., Mauer, D., Michel, K., Legler, A., Becker, A., Monory, K., Lutz, B., Zimmer, A., Bilkei-Gorzo, A., Role of CB1 cannabinoid receptors on GABAergic neurons in brain aging. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 11256–11261.
2. Alpar, A., Tortoriello, G., Calvigioni, D., Niphakis, M.J., Milenkovic, I., Bakker, J., Cameron, G.A., Hanics, J., Morris, C.V., Fuzik, J., Kovacs, G.G., Cravatt, B.F., Parnavelas, J.G., Andrews, W.D., Hurd, Y.L., Keimpema, E., Harkany, T., Endocannabinoids modulate cortical development by configuring Slit2/Robo1 signalling. Nat. Commun., 5, 2014, 4421.
3. Alpar, A., Di Marzo, V., Harkany, T., At the tip of an iceberg: prenatal marijuana and its possible relation to neuropsychiatric outcome in the offspring. Biol. Psychiatry 79 (2016), e33–45.
4. Astley, S.J., Little, R.E., Maternal marijuana use during lactation and infant development at one year. Neurotoxicol Teratol. 12 (1990), 161–168.
5. Belluomo, I., Matias, I., Pernègre, C., Marsicano, G., Chaouloff, F., Opposite control of frontocortical 2-arachidonoylglycerol turnover rate by cannabinoid type-1 receptors located on glutamatergic neurons and on astrocytes. J. Neurochem. 133 (2015), 26–37.
6. Berghuis, P., Rajnicek, A.M., Morozov, Y.M., Ross, R.A., Mulder, J., Urban, G.M., Monory, K., Marsicano, G., Matteoli, M., Canty, A., Irving, A.J., Katona, I., Yanagawa, Y., Rakic, P., Lutz, B., Mackie, K., Harkany, T., Hardwiring the brain: endocannabinoids shape neuronal connectivity. Science 316 (2007), 1212–1216.
7. Berridge, K.C., Robinson, T.E., What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?. Brain Res. Brain Res. Rev. 28 (1998), 309–369.
8. Bilbo, S.D., Schwarz, J.M., The immune system and developmental programming of brain and behavior. Front. Neuroendocrinol. 33 (2012), 267–286.
9. Bonnin, A., de Miguel, R., Hernandez, M.L., Ramos, J.A., Fernandez-Ruiz, J.J., The prenatal exposure to delta 9-tetrahydrocannabinol affects the gene expression and the activity of tyrosine hydroxylase during early brain development. Life Sci. 56 (1995), 2177–2184.
10. Bonnin, A., de Miguel, R., Castro, J.G., Ramos, J.A., Fernandez-Ruiz, J.J., Effects of perinatal exposure to delta 9-tetrahydrocannabinol on the fetal and early postnatal development of tyrosine hydroxylase-containing neurons in rat brain. J. Mol. Neurosci. 7 (1996), 291–308.
11. Borgelt, L.M., Franson, K.L., Nussbaum, A.M., Wang, G.S., The pharmacologic and clinical effects of medical cannabis. Pharmacotherapy 33 (2013), 195–209.
12. Bosier, B., Bellocchio, L., Metna-Laurent, M., Soria-Gomez, E., Matias, I., Hebert-Chatelain, E., Cannich, A., Maitre, M., Leste-Lasserre, T., Cardinal, P., Mendizabal-Zubiaga, J., Canduela, M.J., Reguero, L., Hermans, E., Grandes, P., Cota, D., Marsicano, G., Astroglial CB1 cannabinoid receptors regulate leptin signaling in mouse brain astrocytes. Mol. Metab. 2 (2013), 393–404.
13. Brown, R.M., Kupchik, Y.M., Kalivas, P.W., The story of glutamate in drug addiction and of N-acetylcysteine as a potential pharmacotherapy. JAMA Psychiatry 70 (2013), 895–897.
14. Byrnes, J.J., Johnson, N.L., Schenk, M.E., Byrnes, E.M., Cannabinoid exposure in adolescent female rats induces transgenerational effects on morphine conditioned place preference in male offspring. J. Psychopharmacol. 26 (2012), 1348–1354.
15. Cabral, G.A., Griffin-Thomas, L., Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation. Expert Rev. Mol. Med., 11, 2009, e3.
16. Cabral, G.A., Rogers, T.J., Lichtman, A.H., Turning over a new leaf: cannabinoid and endocannabinoid modulation of immune function. J. Neuroimmune Pharmacol. 10 (2015), 193–203.
17. Caille, S., Clemens, K., Stinus, L., Cador, M., Modeling nicotine addiction in rats. Methods Mol. Biol. 829 (2012), 243–256.
18. Calvigioni, D., Hurd, Y.L., Harkany, T., Keimpema, E., Neuronal substrates and functional consequences of prenatal cannabis exposure. Eur. Child. Adolesc. Psychiatry 23 (2014), 931–941.
19. Cardinal, R.N., Everitt, B.J., Neural and psychological mechanisms underlying appetitive learning: links to drug addiction. Curr. Opin. Neurobiol. 14 (2004), 156–162.
20. Carlisle, S.J., Marciano-Cabral, F., Staab, A., Ludwick, C., Cabral, G.A., Differential expression of the CB2 cannabinoid receptor by rodent macrophages and macrophage-like cells in relation to cell activation. Int. Immunopharmacol. 2 (2002), 69–82.
21. Carrier, E.J., Kearn, C.S., Barkmeier, A.J., Breese, N.M., Yang, W., Nithipatikom, K., Pfister, S.L., Campbell, W.B., Hillard, C.J., Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism. Mol. Pharmacol. 65 (2004), 999–1007.
22. Colizzi, M., McGuire, P., Pertwee, R.G., Bhattacharyya, S., Effect of cannabis on glutamate signalling in the brain: a systematic review of human and animal evidence. Neurosci. Biobehav Rev. 64 (2016), 359–381.
23. Cortes-Briones, J., Skosnik, P.D., Mathalon, D., Cahill, J., Pittman, B., Williams, A., Sewell, R.A., Ranganathan, M., Roach, B., Ford, J., D'Souza, D.C., Δ9-THC disrupts gamma (γ)-Band neural oscillations in humans. Neuropsychopharmacology 40 (2015), 2124–2134.
24. Cutando, L., Busquets-Garcia, A., Puighermanal, E., Gomis-González, M., Delgado-García, J.M., Gruart, A., Maldonado, R., Ozaita, A., Microglial activation underlies cerebellar deficits produced by repeated cannabis exposure. J. Clin. Invest 123 (2013), 2816–2831.
25. Day, N.L., Richardson, G.A., Prenatal marijuana use: epidemiology, methodologic issues, and infant outcome. Clin. Perinatol. 18 (1991), 77–91.
26. Day, N., Sambamoorthi, U., Taylor, P., Richardson, G., Robles, N., Jhon, Y., Scher, M., Stoffer, D., Cornelius, M., Jasperse, D., Prenatal marijuana use and neonatal outcome. Neurotoxicol Teratol. 13 (1991), 329–334.
27. Day, N.L., Goldschmidt, L., Thomas, C.A., Prenatal marijuana exposure contributes to the prediction of marijuana use at age 14. Addiction 101 (2006), 1313–1322.
28. de Salas-Quiroga, A., Diaz-Alonso, J., Garcia-Rincon, D., Remmers, F., Vega, D., Gomez-Canas, M., Lutz, B., Guzman, M., Galve-Roperh, I., Prenatal exposure to cannabinoids evokes long-lasting functional alterations by targeting CB1 receptors on developing cortical neurons. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), 13693–13698.
29. Díaz-Alonso, J., Aguado, T., Wu, C.S., Palazuelos, J., Hofmann, C., Garcez, P., Guillemot, F., Lu, H.C., Lutz, B., Guzmán, M., Galve-Roperh, I., The CB1 cannabinoid receptor drives corticospinal motor neuron differentiation through the Ctip2/Satb2 transcriptional regulation axis. J. Neurosci. 32 (2012), 16651–16665.
30. DiNieri, J.A., Wang, X., Szutorisz, H., Spano, S.M., Kaur, J., Casaccia, P., Dow-Edwards, D., Hurd, Y.L., Maternal cannabis use alters ventral striatal dopamine D2 gene regulation in the offspring. Biol. Psychiatry 70 (2011), 763–769.
31. Dirikoc, S., Priola, S.A., Marella, M., Zsurger, N., Chabry, J., Nonpsychoactive cannabidiol prevents prion accumulation and protects neurons against prion toxicity. J. Neurosci. 27 (2007), 9537–9544.
32. Dishion, T.J., Capaldi, D.M., Yoerger, K., Middle childhood antecedents to progressions in male adolescent substance use: an ecological analysis of risk and protection. J. Adolesc. Res., 1999, 175–205.
33. Domercq, M., Vázquez-Villoldo, N., Matute, C., Neurotransmitter signaling in the pathophysiology of microglia. Front. Cell Neurosci., 19(7), 2013, 49.
34. Ebrahim, S.H., Gfroerer, J., Pregnancy-related substance use in the United States during 1996-1998. Obstet. Gynecol. 101 (2003), 374–379.
35. Eljaschewitsch, E., Wittin, g.A., Mawrin, C., Lee, T., Schmidt, P.M., Wolf, S., Hoertnagl, H., Raine, C.S., Schneider-Stock, R., Nitsch, R., Ullrich, O., The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells. Neuron 49 (2006), 67–79.
36. Fattore, L., Fratta, W., Beyond THC: the new generation of cannabinoid designer drugs. Front. Behav. Neurosci., 5, 2011, 60.
37. Feng, J., Nestler, E.J., Epigenetic mechanisms of drug addiction. Curr. Opin. Neurobiol. 23 (2013), 521–528.
38. Fergusson, D.M., Horwood, L.J., Northstone, K., Maternal use of cannabis and pregnancy outcome. BJOG 109 (2002), 21–27.
39. French, L., Gray, C., Leonard, G., Perron, M., Pike, G.B., Richer, L., Seguin, J.R., Veillette, S., Evans, C.J., Artiges, E., Banaschewski, T., Bokde, A.W., Bromberg, U., Bruehl, R., Buchel, C., Cattrell, A., Conrod, P.J., Flor, H., Frouin, V., Gallinat, J., Garavan, H., Gowland, P., Heinz, A., Lemaitre, H., Martinot, J.L., Nees, F., Orfanos, D.P., Pangelinan, M.M., Poustka, L., Rietschel, M., Smolka, M.N., Walter, H., Whelan, R., Timpson, N.J., Schumann, G., Smith, G.D., Pausova, Z., Paus, T., Early cannabis use, polygenic risk score for schizophrenia and brain maturation in adolescence. JAMA Psychiatry 72 (2015), 1002–1011.
40. Fried, P.A., Smith, A.M., A literature review of the consequences of prenatal marihuana exposure. An emerging theme of a deficiency in aspects of executive function. Neurotoxicol Teratol. 23 (2001), 1–11.
41. Friedrich, J., Khatib, D., Parsa, K., Santopietro, A., Gallicano, G.I., The grass isn't always greener: the effects of cannabis on embryological development. BMC Pharmacol. Toxicol., 17, 2016, 45.
42. Galve-Roperh, I., Chiurchiu, V., Diaz-Alonso, J., Bari, M., Guzman, M., Maccarrone, M., Cannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation. Prog. Lipid Res. 52 (2013), 633–650.
43. Gomez, M., Hernandez, M., Johansson, B., de Miguel, R., Ramos, J.A., Fernandez-Ruiz, J., Prenatal cannabinoid and gene expression for neural adhesion molecule L1 in the fetal rat brain. Brain research. Dev. brain Res. 147 (2003), 201–207.
44. Gorelick, D.A., Pharmacological treatment of cannabis-related disorders: a narrative review. Curr. Pharm. Des. 22 (2016), 6409–6419.
45. Graeber, M.B., Changing face of microglia. Science 330 (2012), 783–788.
46. Han, J., Kesner, P., Metna-Laurent, M., Duan, T., Xu, L., Georges, F., Koehl, M., Abrous, D.N., Mendizabal-Zubiaga, J., Grandes, P., Liu, Q., Bai, G., Wang, W., Xiong, L., Ren, W., Marsicano, G., Zhang, X., Acute cannabinoids impair working memory through astroglial CB1 receptor modulation of hippocampal LTD. Cell 148 (2012), 1039–1050.
47. Harbison, R.D., Mantilla-Plata, B., Prenatal toxicity, maternal distribution and placental transfer of tetrahydrocannabinol. J. Pharmacol. Exp. Ther. 180 (1972), 446–453.
48. Harkany, T., Guzman, M., Galve-Roperh, I., Berghuis, P., Devi, L.A., Mackie, K., The emerging functions of endocannabinoid signaling during CNS development. Trends Pharmacol. Sci. 28 (2007), 83–92.
49. Harris, A.C., Mattson, C., Lesage, M.G., Keyler, D.E., Pentel, P.R., Comparison of the behavioral effects of cigarette smoke and pure nicotine in rats. Pharmacol. Biochem. Behav. 96 (2010), 217–227.
50. Hashimotodani, Y., Ohno-Shosaku, T., Maejima, T., Fukami, K., Kano, M., Pharmacological evidence for the involvement of diacylglycerol lipase in depolarization-induced endocanabinoid release. Neuropharmacology 54 (2008), 58–67 Epub 2007 Jun 22.
51. Haydon, P.G., Blendy, J., Moss, S.J., Rob Jackson, F., Astrocytic control of synaptic transmission and plasticity: a target for drugs of abuse?. Neuropharmacology 1 (2009), 83–90.
52. Huestis, M.A., Pharmacokinetics and metabolism of plant cannabinoids, delta9-tetrahydrocannabinol, cannabidiol, and cannabinol. Handb. Exp. Pharmacol. 168 (2005), 657–690.
53. Hurd, Y.L., Wang, X., Anderson, V., Beck, O., Minkoff, H., Dow-Edwards, D., Marijuana impairs growth in mid-gestation fetuses. Neurotoxicol Teratol. 27 (2005), 221–229.
54. Hurd, Y.L., Michaelides, M., Miller, M.L., Jutras-Aswad, D., Trajectory of adolescent cannabis use on addiction vulnerability. Neuropharmacology 76:Pt B (2014), 416–424.
55. Hutchings, D.E., Martin, B.R., Gamagaris, Z., Miller, N., Fico, T., Plasma concentrations of delta-9-tetrahydrocannabinol in dams and fetuses following acute or multiple prenatal dosing in rats. Life Sci. 44 (1989), 697–701.
56. Iseger, T.A., Bossong, M.G., A systematic review of the antipsychotic properties of cannabidiol in humans. Schizophr. Res. 162 (2015), 153–161.
57. Jaques, S.C., Kingsbury, A., Henshcke, P., Chomchai, C., Clews, S., Falconer, J., Abdel-Latif, M.E., Feller, J.M., Oei, J.L., Cannabis, the pregnant woman and her child: weeding out the myths. J. Perinatol. 34 (2014), 417–424.
58. Justinova, Z., Tanda, G., Redhi, G.H., Goldberg, S.R., Self-administration of delta9-tetrahydrocannabinol (THC) by drug naive squirrel monkeys. Psychopharmacol. Berl. 169 (2003), 135–140.
59. Justinova, Z., Munzar, P., Panlilio, L.V., Yasar, S., Redhi, G.H., Tanda, G., Goldberg, S.R., Blockade of THC-seeking behavior and relapse in monkeys by the cannabinoid CB(1)-receptor antagonist rimonabant. Neuropsychopharmacology 33 (2008), 2870–2877.
60. Jutras-Aswad, D., DiNieri, J.A., Harkany, T., Hurd, Y.L., Neurobiological consequences of maternal cannabis on human fetal development and its neuropsychiatric outcome. Eur. Arch. Psychiatry Clin. Neurosci. 259 (2009), 395–412.
61. Kalivas, P.W., Volkow, N.D., New medications for drug addiction hiding in glutamatergic neuroplasticity. Mol. psychiatry 16 (2011), 974–986.
62. Katsidoni, V., Kastellakis, A., Panagis, G., Biphasic effects of Delta9-tetrahydrocannabinol on brain stimulation reward and motor activity. Int. J. Neuropsychopharmacol. 16 (2013), 2273–2284.
63. Kawash, G.F., Yeung, D.L., Berg, S.D., Effects of administration of cannabis resin during pregnancy on emotionality and learning in rats' offspring. Percept. Mot. Ski. 50 (1980), 359–365.
64. Keimpema, E., Mackie, K., Harkany, T., Molecular model of cannabis sensitivity in developing neuronal circuits. Trends Pharmacol. Sci. 32 (2011), 551–561.
65. Kettenmann, H., Kirchhoff, F., Verkhratsky, A., Microglia: new roles for the synaptic stripper. Neuron 77 (2013), 10–18.
66. Khare, M., Taylor, A.H., Konje, J.C., Bell, S.C., Delta9-tetrahydrocannabinol inhibits cytotrophoblast cell proliferation and modulates gene transcription. Mol. Hum. Reprod. 12 (2006), 321–333.
67. Lacagnina, M.J., Rivera, P.D., Bilbo, S.D., Glial and neuroimmune mechanisms as critical modulators of drug use and abuse. Neuropsychopharmacology 42 (2017), 156–177.
68. Lefever, T.W., Marusich, J.A., Antonazzo, K.R., Wiley, J.L., Evaluation of WIN 55,212-2 self-administration in rats as a potential cannabinoid abuse liability model. Pharmacol. Biochem. Behav. 118 (2014), 30–35.
69. Lepore, M., Vorel, S.R., Lowinson, J., Gardner, E.L., Conditioned place preference induced by delta 9-tetrahydrocannabinol: comparison with cocaine, morphine, and food reward. Life Sci. 56 (1995), 2073–2080.
70. Liang, S.L., Alger, B.E., McCarthy, M.M., Developmental increase in hippocampal endocannabinoid mobilization: role of metabotropic glutamate receptor subtype 5 and phospholipase C. J. Neurophysiol. 112 (2014), 2605–2615.
71. Lopez-Rodriguez, A.B., Llorente-Berzal, A., Garcia-Segura, L.M., Viveros, M.P., Sex-dependent long-term effects of adolescent exposure to THC and/or MDMA on neuroinflammation and serotoninergic and cannabinoid systems in rats. Br. J. Pharmacol. 171 (2014), 1435–1447.
72. Lorenzetti, V., Solowij, N., Yücel, M., The role of cannabinoids in neuroanatomic alterations in cannabis users. Biol. Psychiatry 79 (2016), e17–31.
73. De Luca, M.A., Bimpisidis, Z., Melis, M., Marti, M., Caboni, P., Valentini, V., Margiani, G., Pintori, N., Polis, I., Marsicano, G., Parsons, L.H., Di Chiara, G., Stimulation of in vivo dopamine transmission and intravenous self-administration in rats and mice by JWH-018, a Spice cannabinoid. Neuropharmacology 99 (2015), 705–714.
74. De Luca, M.A., Castelli, M.P., Loi, B., Porcu, A., Martorelli, M., Miliano, C., Kellett, K., Davidson, C., Stair, J.L., Schifano, F., Di Chiara, G., Native CB1 receptor affinity, intrinsic activity and accumbens shell dopamine stimulant properties of third generation SPICE/K2 cannabinoids: BB-22, 5F-PB-22, 5F-AKB-48 and STS-135. Neuropharmacology 105 (2016), 630–638.
75. Maldonado, R., Study of cannabinoid dependence in animals. Pharmacol. Ther. 95 (2002), 153–164.
76. Marsicano, G., Lutz, B., Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. Eur. J. Neurosci. 11 (1999), 4213–4225.
77. McBride, D.L., Marijuana may harm developing brains. J. Pediatr. Nurs. 29 (2014), 376–377.
78. Mehmedic, Z., Chandra, S., Slade, D., Denham, H., Foster, S., Patel, A.S., Ross, S.A., Khan, I.A., ElSohly, M.A., Potency trends of Delta9-THC and other cannabinoids in confiscated cannabis preparations from 1993 to 2008. J. Forensic Sci. 55 (2010), 1209–1217.
79. Melis, M., Pistis, M., Hub and switches: endocannabinoid signalling in midbrain dopamine neurons. Philos. Trans. R. Soc. Lond B Biol. Sci. 367 (2012), 3276–3285.
80. Mereu, G., Fà, M., Ferraro, L., Cagiano, R., Antonelli, T., Tattoli, M., Ghiglieri, V., Tanganelli, S., Gessa, G.L., Cuomo, V., Prenatal exposure to a cannabinoid agonist produces memory deficits linked to dysfunction in hippocampal long-term potentiation and glutamate release. Proc. Natl. Acad. Sci. U. S. A. 100 (2003), 4915–4920.
81. Moore, D.G., Turner, J.D., Parrott, A.C., Goodwin, J.E., Fulton, S.E., Min, M.O., Fox, H.C., Braddick, F.M., Axelsson, E.L., Lynch, S., Ribeiro, H., Frostick, C.J., Singer, L.T., During pregnancy, recreational drug-using women stop taking ecstasy (3,4-methylenedioxy-N-methylamphetamine) and reduce alcohol consumption, but continue to smoke tobacco and cannabis: initial findings from the Development and Infancy Study. J. Psychopharmacol. 24 (2010), 1403–1410.
82. Morris, C.V., DiNieri, J.A., Szutorisz, H., Hurd, Y.L., Molecular mechanisms of maternal cannabis and cigarette use on human neurodevelopment. Eur. J. Neurosci. 34 (2011), 1574–1583.
83. Nagarkatti, P., Pandey, R., Rieder, S.A., Hegde, V.L., Nagarkatti, M., Cannabinoids as novel anti-inflammatory drugs. Future Med. Chem. 1 (2009), 1333–1349.
84. Navarrete, M., Araque, A., Endocannabinoids mediate neuron-astrocyte communication. Neuron 57 (2008), 883–893.
85. Navarrete, M., Araque, A., Endocannabinoids potentiate synaptic transmission through stimulation of astrocytes. Neuron 68 (2010), 113–126.
86. Navarrete, M., Díez, A., Araque, A., Astrocytes in endocannabinoid signalling. Philos. Trans. R. Soc. Lond B Biol. Sci., 369, 2014, 20130599.
87. Navarro, M., Rubio, P., de Fonseca, F.R., Behavioural consequences of maternal exposure to natural cannabinoids in rats. Psychopharmacol. Berl. 122 (1995), 1–14.
88. Navarro, G., Morales, P., Rodríguez-Cueto, C., Fernández-Ruiz, J., Jagerovic, N., Franco, R., Targeting cannabinoid CB2 receptors in the central nervous system. Medicinal chemistry approaches with focus on neurodegenerative disorders. Front. Neurosci., 10, 2016, 406.
89. Oleson, E.B., Beckert, M.V., Morra, J.T., Lansink, C.S., Cachope, R., Abdullah, R.A., Loriaux, A.L., Schetters, D., Pattij, T., Roitman, M.F., Lichtman, A.H., Cheer, J.F., Endocannabinoids shape accumbal encoding of cue-motivated behavior via CB1 receptor activation in the ventral tegmentum. Neuron 73 (2012), 360–373.
90. Panlilio, L.V., Goldberg, S.R., Justinova, Z., Cannabinoid abuse and addiction: clinical and preclinical findings. Clin. Pharmacol. Ther. 97 (2015), 616–627.
91. Perez-Reyes, M., Wall, M.E., Presence of delta9-tetrahydrocannabinol in human milk. N. Engl. J. Med. 307 (1982), 819–820.
92. Pertwee, R.G., The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. Br. J. Pharmacol. 153 (2008), 199–215.
93. Porath, A.J., Fried, P.A., Effects of prenatal cigarette and marijuana exposure on drug use among offspring. Neurotoxicol Teratol. 27 (2005), 267–277.
94. Psychoyos, D., Vinod, K.Y., Marijuana, Spice 'herbal high', and early neural development: implications for rescheduling and legalization. Drug Test. Anal. 5 (2013), 27–45.
95. Psychoyos, D., Hungund, B., Cooper, T., Finnell, R.H., A cannabinoid analogue of Delta9-tetrahydrocannabinol disrupts neural development in chick. Birth Defects Res. B Dev. Reprod. Toxicol. 83 (2008), 477–488.
96. Radhakrishnan, R., Skosnik, P.D., Cortes-Briones, J., Sewell, R.A., Carbuto, M., Schnakenberg, A., Cahill, J., Bois, F., Gunduz-Bruce, H., Pittman, B., Ranganathan, M., D'Souza, D.C., GABA deficits enhance the psychotomimetic effects of Δ9-THC. Neuropsychopharmacology 40 (2015), 2047–2056.
97. Ramirez, B.G., Blazquez, C., Gomez del Pulgar, T., Guzman, M., de Ceballos, M.L., Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation. J. Neurosci. 25 (2005), 1904–1913.
98. Rodriguez de Fonseca, F., Cebeira, M., Fernandez-Ruiz, J.J., Navarro, M., Ramos, J.A., Effects of pre- and perinatal exposure to hashish extracts on the ontogeny of brain dopaminergic neurons. Neuroscience 43 (1991), 713–723.
99. Rubino, T., Parolaro, D., The impact of exposure to cannabinoids in adolescence: insights from animal models. Biol. Psychiatry 79 (2016), 578–585.
100. Rubino, T., Prini, P., Piscitelli, F., Zamberletti, E., Trusel, M., Melis, M., Sagheddu, C., Ligresti, A., Tonini, R., Di Marzo, V., Parolaro, D., Adolescent exposure to THC in female rats disrupts developmental changes in the prefrontal cortex. Neurobiol. Dis. 73 (2015), 60–69.
101. Russo, E., Guy, G.W., A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol. Med. Hypotheses 66 (2006), 234–246.
102. Saez, T.M., Aronne, M.P., Caltana, L., Brusco, A.H., Prenatal exposure to the CB1 and CB2 cannabinoid receptor agonist WIN 55,212-2 alters migration of early-born glutamatergic neurons and GABAergic interneurons in the rat cerebral cortex. J. Neurochem. 129 (2014), 637–648.
103. Schafer, D.P., Stevens, B., Phagocytic glial cells: sculpting synaptic circuits in the developing nervous system. Curr. Opin. Neurobiol. 23 (2013), 1034–1040.
104. Schneider, M., Cannabis use in pregnancy and early life and its consequences: animal models. Eur. Arch. Psychiatry Clin. Neurosci. 259 (2009), 383–393.
105. Scofield, M.D., Li, H., Siemsen, B.M., Healey, K.L., Tran, P.K., Woronoff, N., Boger, H.A., Kalivas, P.W., Reissner, K.J., Cocaine self-administration and extinction leads to reduced glial fibrillary acidic protein expression and morphometric features of astrocytes in the nucleus accumbens core. Biol. Psychiatry 80 (2015), 207–215.
106. Shaham, Y., Shalev, U., Lu, L., De Wit, H., Stewart, J., The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacol. Berl. 168 (2003), 3–20.
107. Skosnik, P.D., Edwards, C.R., O'Donnell, B.F., Steffen, A., Steinmetz, J.E., Hetrick, W.P., Cannabis use disrupts eyeblink conditioning: evidence for cannabinoid modulation of cerebellar-dependent learning. Neuropsychopharmacology 33 (2008), 1432–1440.
108. Skosnik, P.D., Krishnan, G.P., D'Souza, D.C., Hetrick, W.P., O'Donnell, B.F., Disrupted gamma-band neural oscillations during coherent motion perception in heavy cannabis users. Neuropsychopharmacology 39 (2014), 3087–3099.
109. Solinas, M., Zangen, A., Thiriet, N., Goldberg, S.R., Beta-endorphin elevations in the ventral tegmental area regulate the discriminative effects of Delta-9-tetrahydrocannabinol. Eur. J. Neurosci. 19 (2004), 3183–3192.
110. Spano, M.S., Ellgren, M., Wang, X., Hurd, Y.L., Prenatal cannabis exposure increases heroin seeking with allostatic changes in limbic enkephalin systems in adulthood. Biol. Psychiatry 61 (2007), 554–563.
111. Spencer, S., Scofield, M., Kalivas, P.W., The good and bad news about glutamate in drug addiction. J. Psychopharmacol. 30 (2016), 1095–1098.
112. Steinmetz, A.B., Edwards, C.R., Vollmer, J.M., Erickson, M.A., O'Donnell, B.F., Hetrick, W.P., Skosnik, P.D., Examining the effects of former cannabis use on cerebellum-dependent eyeblink conditioning in humans. Psychopharmacol. Berl. 221 (2012), 133–141.
113. Stella, N., Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas. Glia 58 (2010), 1017–1030.
114. Szutorisz, H., Hurd, Y.L., Epigenetic effects of cannabis exposure. Biol. psychiatry 79 (2016), 586–594.
115. Szutorisz, H., DiNieri, J.A., Sweet, E., Egervari, G., Michaelides, M., Carter, J.M., Ren, Y., Miller, M.L., Blitzer, R.D., Hurd, Y.L., Parental THC exposure leads to compulsive heroin-seeking and altered striatal synaptic plasticity in the subsequent generation. Neuropsychopharmacology 39 (2014), 1315–1323.
116. Szutorisz, H., Egervari, G., Sperry, J., Carter, J.M., Hurd, Y.L., Cross-generational THC exposure alters the developmental sensitivity of ventral and dorsal striatal gene expression in male and female offspring. Neurotoxicology Teratol. 58 (2016), 107–114.
117. Tanda, G., Munzar, P., Goldberg, S.R., Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys. Nat. Neurosci. 3 (2000), 1073–1074.
118. Tortoriello, G., Morris, C.V., Alpar, A., Fuzik, J., Shirran, S.L., Calvigioni, D., Keimpema, E., Botting, C.H., Reinecke, K., Herdegen, T., Courtney, M., Hurd, Y.L., Harkany, T., Miswiring the brain: delta9-tetrahydrocannabinol disrupts cortical development by inducing an SCG10/stathmin-2 degradation pathway. EMBO J. 33 (2014), 668–685.
119. United Nations Office on Drugs and Crime, World Drug Report, (United Nations Publication, Sales No. E.16.XI.7). 2016.
120. Valjent, E., Maldonado, R., A behavioural model to reveal place preference to delta 9-tetrahydrocannabinol in mice. Psychopharmacol. Berl. 147 (2000), 436–438.
121. van Gelder, M.M., Reefhuis, J., Caton, A.R., Werler, M.M., Druschel, C.M., Roeleveld, N., Maternal periconceptional illicit drug use and the risk of congenital malformations. Epidemiology 20 (2009), 60–66.
122. Vann, R.E., Gamage, T.F., Warner, J.A., Marshall, E.M., Taylor, N.L., Martin, B.R., Wiley, J.L., Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of Delta(9)-tetrahydrocannabinol. Drug Alcohol Depend. 94 (2008), 191–198.
123. Vargish, G.A., Pelkey, K.A., Yuan, X., Chittajallu, R., Collins, D., Fang, C., McBain, C.J., Persistent inhibitory circuit defects and disrupted social behaviour following in utero exogenous cannabinoid exposure. Mol. Psychiatry 22 (2016), 56–67.
124. Vassoler, F.M., Sadri-Vakili, G., Mechanisms of transgenerational inheritance of addictive-like behaviors. Neuroscience 264 (2014), 198–206.
125. Vassoler, F.M., Johnson, N.L., Byrnes, E.M., Female adolescent exposure to cannabinoids causes transgenerational effects on morphine sensitization in female offspring in the absence of in utero exposure. J. Psychopharmacol. 27 (2013), 1015–1022.
126. Vassoler, F.M., Byrnes, E.M., Pierce, R.C., The impact of exposure to addictive drugs on future generations: physiological and behavioral effects. Neuropharmacology 76:Pt B (2014), 269–275.
127. Vitalis, T., Laine, J., Simon, A., Roland, A., Leterrier, C., Lenkei, Z., The type 1 cannabinoid receptor is highly expressed in embryonic cortical projection neurons and negatively regulates neurite growth in vitro. Eur. J. Neurosci. 28 (2008), 1705–1718.
128. Volkow, N.D., Fowler, J.S., Wang, G.J., Swanson, J.M., Telang, F., Dopamine in drug abuse and addiction: results of imaging studies and treatment implications. Arch. Neurol. 64 (2007), 1575–1579.
129. Volkow, N.D., Wang, G.J., Fowler, J.S., Tomasi, D., Telang, F., Addiction: beyond dopamine reward circuitry. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 15037–15042.
130. Volkow, N.D., Baler, R.D., Compton, W.M., Weiss, S.R., Adverse health effects of marijuana use. N. Engl. J. Med. 370 (2014), 2219–2227.
131. Walter, L., Franklin, A., Witting, A., Wade, C., Xie, Y., Kunos, G., Mackie, K., Stella, N., Nonpsychotropic cannabinoid receptors regulate microglial cell migration. J. Neurosci. 23 (2003), 1398–1405.
132. Wang, H., Lupica, C.R., Release of endogenous cannabinoids from ventral tegmental area dopamine neurons and the modulation of synaptic processes. Prog. Neuropsychopharmacol. Biol. Psychiatry 52 (2014), 24–27.
133. Wang, X., Dow-Edwards, D., Anderson, V., Minkoff, H., Hurd, Y.L., In utero marijuana exposure associated with abnormal amygdala dopamine D2 gene expression in the human fetus. Biol. Psychiatry 56 (2004), 909–915.
134. Wang, X., Dow-Edwards, D., Anderson, V., Minkoff, H., Hurd, Y.L., Discrete opioid gene expression impairment in the human fetal brain associated with maternal marijuana use. Pharmacogenomics J. 6 (2006), 255–264.
135. Watson, C.T., Szutorisz, H., Garg, P., Martin, Q., Landry, J.A., Sharp, A.J., Hurd, Y.L., Genome-wide DNA methylation profiling reveals epigenetic changes in the rat nucleus accumbens associated with cross-generational effects of adolescent THC exposure. Neuropsychopharmacology 40 (2015), 2993–3005.
136. Wenzel, J.M., Cheer, J.F., Endocannabinoid-dependent modulation of phasic dopamine signaling encodes external and internal reward-predictive cues. Front. Psychiatry, 5, 2014, 118.
137. Wise, R.A., Dopamine, learning and motivation. Nat. Rev. Neurosci. 5 (2004), 483–494.
138. Wu, C.S., Zhu, J., Wager-Miller, J., Wang, S., O'Leary, D., Monory, K., Lutz, B., Mackie, K., Lu, H.C., Requirement of cannabinoid CB(1) receptors in cortical pyramidal neurons for appropriate development of corticothalamic and thalamocortical projections. Eur. J. Neurosci. 32 (2010), 693–706.
139. Zamberletti, E., Beggiato, S., Steardo, L. Jr., Prini, P., Antonelli, T., Ferraro, L., Rubino, T., Parolaro, D., Alterations of prefrontal cortex GABAergic transmission in the complex psychotic-like phenotype induced by adolescent delta-9-tetrahydrocannabinol exposure in rats. Neurobiol. Dis. 63 (2014), 35–47.
140. Zamberletti, E., Gabaglio, M., Prini, P., Rubino, T., Parolaro, D., Cortical neuroinflammation contributes to long-term cognitive dysfunctions following adolescent delta-9-tetrahydrocannabinol treatment in female rats. Eur. Neuropsychopharmacol. 25 (2015), 2404–2415.
141. Zamberletti, E., Gabaglio, M., Grilli, M., Prini, P., Catanese, A., Pittaluga, A., Marchi, M., Rubino, T., Parolaro, D., Long-term hippocampal glutamate synapse and astrocyte dysfunctions underlying the altered phenotype induced by adolescent THC treatment in male rats. Pharmacol. Res. 111 (2016), 459–470.
142. Zangen, A., Solinas, M., Ikemoto, S., Goldberg, S.R., Wise, R.A., Two brain sites for cannabinoid reward. J. Neurosci. 26 (2006), 4901–4907.
143. Zernig, G., Ahmed, S.H., Cardinal, R.N., Morgan, D., Acquas, E., Foltin, R.W., Vezina, P., Negus, S.S., Crespo, J.A., Stockl, P., Grubinger, P., Madlung, E., Haring, C., Kurz, M., Saria, A., Explaining the escalation of drug use in substance dependence: models and appropriate animal laboratory tests. Pharmacology 80 (2007), 65–119.
144. Zhang, H.Y., Gao, M., Liu, Q.R., Bi, G.H., Li, X., Yang, H.J., Gardner, E.L., Wu, J., Xi, Z.X., Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice. Proc. Natl. Acad. Sci. U. S. A. 111 (2014), E5007–E5015.